製品情報

SCCA2キット

1. Yuyama N, Davies DE, Akaiwa M, Matsui K, Hamasaki Y, Suminami Y, et al.
   Analysis of novel disease-related genes in bronchial asthma. 　Cytokine 2002;19:287-296
2. Okawa T, Yamaguchi Y, Kou K, Ono J, Azuma Y, Komitsu N, Inoue Y, et al.
   Serum levels of squamous cell carcinoma antigens 1 and 2 reflect disease
   severity and clinical type of atopic dermatitis in adult patients 　Allergol Int 2018;67:124-130

• Ohta S, Shibata R, Nakao Y, Azuma Y, Taniguchi K, Arima K, et al.
  The usefulness of combined measurements of squamous cell carcinoma
  antigens 1 and 2 in diagnosing atopic dermatitis. 　Ann Clin Biochem 2012;49:277-284
• Nagao M, Inagaki S, Kawano T, Azuma Y, Nomura N, Noguchi Y, Ohta S, et al.
  SCCA2 is a reliable biomarker for evaluating pediatric atopic dermatitis.
  J Allergy Clin Immunol 2018;141:1934-1936
• 藤澤隆夫. 小児アトピー性皮膚炎のバイオマーカー：TARC, そして新しいSCCA2を中心に
  アレルギー 2018; 67: 981-986
• Izuhara K, Yamaguchi Y, Ohta S, Nunomura S, Nanri Y, Azuma Y, et al.
  Squamous Cell Carcinoma Antigen 2 (SCCA2, SERPINB4): An Emerging
  Biomarker for Skin Inflammatory Diseases. 　Int J Mol Sci 2018;19:1102-1117
• Takeuchi S, Furusyo N, Ono J, Azuma Y, Takemura M, Hitokazu Esaki H, et al.
  Serum squamous cell carcinoma antigen (SCCA)-2 correlates with clinical severity
  of pediatric atopic dermatitis in Ishigaki cohort　　J Dermatol Sci 2019; 95: 70–75